We are live on
!
Find out more
Standard BioTools
LAB
LAB
100 hedge funds and large institutions have $229M invested in Standard BioTools in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
21% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 29
13% more call options, than puts
Call options by funds: $1.14M | Put options by funds: $1.01M
6% less funds holding
Funds holding: 106 → 100 (-6)
25% less capital invested
Capital invested by funds: $306M → $229M (-$77.2M)
26% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 23
Holders
100
Holders Change
-6
Holders Change %
-5.66%
% of All Funds
2.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
35
Reduced
29
Closed
23
Calls
$1.14M
Puts
$1.01M
Net Calls
+$133K
Net Calls Change
-$9.86M
Top Buyers
| 1 |
LCS
Levin Capital Strategies
New York
|
+$15.1M |
| 2 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$8.17M |
| 3 |
Jennison Associates
New York
|
+$3.13M |
| 4 |
Neuberger Berman Group
New York
|
+$2.46M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.43M |
Top Sellers
| 1 |
SCM
Scopia Capital Management
New York
|
-$16.3M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$6.62M |
| 3 |
O
OrbiMed
New York
|
-$5.08M |
| 4 |
Goldman Sachs
New York
|
-$4.37M |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$2.91M |
